Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EF5 to Measure Tumor Hypoxia in NSCLC
NCT02154399Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- May 2002
- Primary completion
- Sep 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ef5 in non-small cell lung cancer (NSCLC), sponsored by National Cancer Institute. Started May 2002; status: completed.
02
Drugs
ef5
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02154399.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02154399.